Viking Therapeutic (VKTX) PT Lowered to $85 at Truist Securities

October 7, 2026 7:14 AM

Truist Securities analyst Gregory Renza lowered the price target on Viking Therapeutic (NASDAQ: VKTX) to $85.00 (from $87.00) while maintaining a Buy rating.

No results found